文献速递妇科生殖医学

子宫内膜瘤术后复发:系统综述与荟萃分析

Recurrence after surgery for endometrioma: a systematic review and meta-analyses.
PubMed 文献 · Fertil Steril · 2024-08-05

本系统综述与荟萃分析检索至2023年5月的文献,纳入55项研究(12项随机对照试验、11项前瞻性队列、32项回顾性),对23项研究在随访3、6、12、24个月时汇总分析,未接受术后激素治疗者子宫内膜瘤复发率分别为4%、14%、17%、27%。

要点

  • 未接受术后激素治疗者,术后24个月子宫内膜瘤复发率加权均值最高达27%。
  • 荟萃分析汇总23项研究,随访3、6、12、24个月复发率分别为4%、14%、17%、27%。
  • 55项纳入研究中仅9项随机对照试验和3项非随机研究为低偏倚风险。

核心结论

  • 荟萃分析显示,术后24个月子宫内膜瘤复发率加权均值最高达27%。
  • 本研究旨在确定未使用术后激素治疗的女性手术治疗后子宫内膜瘤复发率,复发率最高达27%。

研究设计与样本

  • 系统综述与荟萃分析,遵循PRISMA指南,检索MEDLINE、Embase和Cochrane图书馆至2023年5月。
  • 文献检索限于接受手术治疗且未接受术后激素治疗的子宫内膜瘤女性。
  • 筛选5367篇文章,97篇系统评价,最终纳入55项研究:12项随机对照试验、11项前瞻性队列研究、32项回顾性研究。
  • 使用Cochrane手册和ROBINS-I工具评估偏倚风险;9项随机对照试验为低偏倚风险,非随机研究中仅3项为低偏倚风险。
  • 23项研究的数据纳入荟萃分析,按随访3、6、12、24个月进行汇总。

主要发现

  • 荟萃分析显示,随访3、6、12、24个月的复发率分别为4%、14%、17%、27%。
  • 24个月时子宫内膜瘤复发率加权均值最高达27%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Endometriosis is an inflammatory disease, with different forms of expression and a variety of complaints. An endometrioma, an ovarian cyst with endometrium-like lining, is one of the most common expressions of abdominal endometriosis. These endometriomas can, in addition to medical treatment, be treated surgically. After surgery, hormonal therapy is still frequently used for the treatment of endometriosis in general and prevention of recurrence of endometriomas specifically. However, not all women want or can receive postoperative hormonal treatment. It is important for this group to determine the risk of anatomical recurrence of ovarian endometrioma after surgery for an endometrioma. OBJECTIVE: To determine the recurrence rate for surgically treated endometrioma without postoperative hormonal treatment. DATA SOURCES: We performed a systematic literature review and meta-analyses, according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. MEDLINE, Embase, and the Cochrane library were searched until May 2023. The literature search was limited to women with endometrioma who received surgical treatment without postoperative hormonal treatment. STUDY SELECTION AND SYNTHESIS: A distinction was made in study design including randomized controlled trials (RCTs) and cohort and retrospective studies. For assessment of risk of bias, the Cochrane Handbook for Systematic Reviews of Interventions and Risk of Bias in Non-randomized Studies - of Interventions assessment tool were used. MAIN OUTCOMES: The outcome measure included in this review was endometrioma recurrence. RESULTS: We screened 5,367 articles, of which 97 were systematically reviewed and 55 were included in this systematic review. Twelve of these were RCTs, 11 were prospective cohort studies, and 32 were retrospective studies. Nine RCTs had a low risk of bias. For non-RCTs, only 3 studies had a low risk of bias. Data of 23 studies were pooled in meta-analyses, performed for follow-up periods of 3, 6, 12, and 24 months. These studies showed recurrence rates of 4%, 14%, 17%, and 27%, respectively. CONCLUSION AND RELEVANCE: In the meta-analysis, at 24 months after surgery, the endometrioma recurrence rate showed a weighted mean of up to 27%. In this study, we aimed to determine the recurrence rate of endometrioma after surgical treatment in women without postoperative hormonal treatment use. The recurrence rates were up to 27%. REGISTRATION NUMBER: CRD42020216541.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Veth VB, Keukens A, Reijs A, et al. Recurrence after surgery for endometrioma: a systematic review and meta-analyses. Fertil Steril. 2024. PMID: 39098538. doi:10.1016/j.fertnstert.2024.07.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。